These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21169326)

  • 1. European drug regulators publish their evaluation of rosiglitazone.
    Mayor S
    BMJ; 2010 Dec; 341():c7278. PubMed ID: 21169326
    [No Abstract]   [Full Text] [Related]  

  • 2. The cardiovascular safety of diabetes drugs--insights from the rosiglitazone experience.
    Hiatt WR; Kaul S; Smith RJ
    N Engl J Med; 2013 Oct; 369(14):1285-7. PubMed ID: 23992603
    [No Abstract]   [Full Text] [Related]  

  • 3. Rosiglitazone: what went wrong?
    Cohen D
    BMJ; 2010 Sep; 341():c4848. PubMed ID: 20819889
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary: What can we learn from the continuing regulatory focus on the thiazolidinediones?
    Freemantle N
    BMJ; 2010 Sep; 341():c4812. PubMed ID: 20819888
    [No Abstract]   [Full Text] [Related]  

  • 5. Licensing drugs for diabetes.
    Lehman R; Yudkin JS; Krumholz H
    BMJ; 2010 Sep; 341():c4805. PubMed ID: 20819887
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA puts rosiglitazone post-marketing trial on hold.
    Cohen D
    BMJ; 2010 Jul; 341():c4017. PubMed ID: 20660507
    [No Abstract]   [Full Text] [Related]  

  • 7. Rosiglitazone and the need for a new drug safety agency.
    Garattini S; Bertele' V
    BMJ; 2010 Oct; 341():c5506. PubMed ID: 20926483
    [No Abstract]   [Full Text] [Related]  

  • 8. GSK is accused of trying to suppress editorial on rosiglitazone.
    Tanne JH
    BMJ; 2010 May; 340():c2654. PubMed ID: 20484354
    [No Abstract]   [Full Text] [Related]  

  • 9. Outlook on diabetes drug less than rosy. Early work suggests that rosiglitazone (Avandia) may not be best for the heart.
    Harv Heart Lett; 2007 Aug; 17(12):1-2. PubMed ID: 17717888
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA committee urges tight restrictions on rosiglitazone.
    Roehr B
    BMJ; 2010 Jul; 341():c3862. PubMed ID: 20639290
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rosiglitazone].
    Johansen K
    Ugeskr Laeger; 2010 Sep; 172(38):2631; author reply 2631. PubMed ID: 20931733
    [No Abstract]   [Full Text] [Related]  

  • 12. Rosiglitazone, marketing, and medical science.
    Moynihan R
    BMJ; 2010 Apr; 340():c1848. PubMed ID: 20375091
    [No Abstract]   [Full Text] [Related]  

  • 13. Analytical issues regarding rosiglitazone meta-analysis.
    Claggett B; Wei LJ
    Arch Intern Med; 2011 Jan; 171(2):179-80; author reply 180. PubMed ID: 21263111
    [No Abstract]   [Full Text] [Related]  

  • 14. The Avandia debate: an unhappy conclusion.
    Bloomgarden Z; Handelsman Y
    J Diabetes; 2010 Dec; 2(4):221-2. PubMed ID: 20923505
    [No Abstract]   [Full Text] [Related]  

  • 15. Rosiglitazone: trials, tribulations and termination.
    Krentz AJ
    Drugs; 2011 Jan; 71(2):123-30. PubMed ID: 21275442
    [No Abstract]   [Full Text] [Related]  

  • 16. The perfect storm--drug safety and rosiglitazone.
    Hellman R
    Endocr Pract; 2007; 13(3):217-8. PubMed ID: 17599850
    [No Abstract]   [Full Text] [Related]  

  • 17. [Suspension of the commercialization of sibutramine and rosiglitazone in Europe].
    Scheen AJ
    Rev Med Liege; 2010 Oct; 65(10):574-9. PubMed ID: 21128363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is rosiglitazone as safe as BARI 2D and the reanalysis of RECORD imply?
    DiNicolantonio JJ; Meier P
    Cardiology; 2014; 127(3):152-4. PubMed ID: 24335113
    [No Abstract]   [Full Text] [Related]  

  • 19. Why the Avandia scandal proves big pharma needs stronger ethical standards.
    Philpott S; Baker R
    Bioethics; 2010 Oct; 24(8):ii-iii. PubMed ID: 21050246
    [No Abstract]   [Full Text] [Related]  

  • 20. Rosiglitazone saga. Demonisation of rosiglitazone.
    Heazlewood VJ
    BMJ; 2011 Apr; 342():d2571; author reply d2573. PubMed ID: 21511791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.